Inflammatory reaction presages response in melanoma skin lesions during i.m. rIFN alpha-2a-based treatment.
Bracarda
S
S
Roila
F
F
Basurto
C
C
Tonato
M
M
D000328:Adult; D003875:Drug Eruptions / Q000276:immunology*; D006801:Humans; D007273:Injections, Intramuscular; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D008545:Melanoma / Q000276:immunology / Q000556:secondary / Q000628:therapy*; D011379:Prognosis; D011994:Recombinant Proteins; D012535:Scalp; D012878:Skin Neoplasms / Q000276:immunology / Q000628:therapy*
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins